CURRENT PATTERNS OF FIXED AND FREE LABA/ICS COMBINATION USAGE IN ASTHMA SHI PATIENTS IN GERMANY

被引：0
|
作者：
Bonthapally, V [1 ]
Wolbring, F. [2 ]
Sindern, J. [2 ]
Mehnert, A. [2 ]
机构：
[1] Univ Louisiana, Monroe, LA USA
[2] Janssen Cilag GmbH, Neuss, NRW, Germany
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A128 / A128
页数：1
相关论文
共 50 条
  • [31] Efficacy of montelukast as complementary therapy to fixed associations ICS/LABA in asthmatic patients with concomitant rhinitis
    Potvin, E
    Korn, D
    Lachman, A
    Gusman, J
    Dramaix, M
    Dupont, L
    Peché, R
    CHEST, 2004, 126 (04) : 721S - 721S
  • [32] Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?
    Patel, Mitesh
    Pilcher, Janine
    Beasley, Richard
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (05) : 451 - 454
  • [33] Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes
    Shiyuan Zhang
    John White
    Alyssa Goolsby Hunter
    David Hinds
    Andrew Fowler
    Frances Gardiner
    David Slade
    Sharanya Murali
    Wilhelmine Meeraus
    npj Primary Care Respiratory Medicine, 33
  • [34] COST-EFECTIVENESS ANALYSIS OF AN INTERVENTION TO REDUCE THE CRITICAL HANDLING ERRORS OF FIXED-DOSE ICS/LABA COMBINATIONS IN ASTHMA PATIENTS IN SPAIN
    Collar Martinez, J. M.
    Roman, M.
    Dominguez, J.
    Perez del Llano, L.
    Crespo, C.
    VALUE IN HEALTH, 2019, 22 : S875 - S875
  • [35] Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes
    Zhang, Shiyuan
    White, John
    Hunter, Alyssa Goolsby
    Hinds, David
    Fowler, Andrew
    Gardiner, Frances
    Slade, David
    Murali, Sharanya
    Meeraus, Wilhelmine
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2023, 33 (01)
  • [36] Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
    Plaza, Vicente
    Dominguez-Ortega, Javier
    Gonzalez-Segura Alsina, Diego
    Lo Re, Daniele
    Sicras-Mainar, Antoni
    PHARMACEUTICALS, 2023, 16 (11)
  • [37] CAPTAIN: Effects of age on response to triple therapy in patients with inadequately controlled asthma on ICS/LABA
    Boulet, Louis-Philippe
    Lee, Laurie
    Kerstjens, Huib
    Papi, Alberto
    Zarankaite, Agne
    Pavord, Ian D.
    Bailes, Zelie
    Brusselle, Guy
    Barnes, Neil
    Hanania, Nicola A.
    Pascoe, Steven
    Oppenheimer, John
    Pizzichini, Emilio
    Fowler, Andrew
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [38] Patterns of ICS Reduction in Patients with Severe Asthma on Mepolizumab
    Corren, J.
    Molfino, N.
    Silver, J.
    Bogart, M.
    Packnett, E.
    McMorrow, D.
    Wu, J.
    Hahn, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
    Kew, Kayleigh M.
    Dahri, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [40] Impact Of Change In Inhaled Corticosteroids/Long-Acting Beta Agonist Combination (ICS/LABA) Use On The Risk Of Asthma Exacerbations In Asthma Patients Within a Medical Group
    Stanford, Richard H.
    Nagar, Saurabh
    Lin, Xiwu
    O'Connor, Dick
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB7 - AB7
12345